Gilead touts analysis showing COVID antiviral Veklury performs best when given early in illness

Coming off a World Health Organization (WHO) recommendation for the use of Veklury in non-hospitalized COVID-19 patients, Gilead Sciences is touting real-world evidence that could help expand the WHO endorsement to those who are hospitalized with a severe infection.